PMH66 QUALITY OF LIFE AND PATIENT-REPORTED OUTCOMES- COMPARISONS OF INDIVIDUALS WITH SCHIZOPHRENIA TREATED WITH ORAL AND LONG-ACTING INJECTABLE FORMULATIONS OF OLANZAPINE
Abstract
Authors
JL Godfrey HC Detke WS Montgomery F Zhao D McDonnell